Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis (ISO-UF)
End Stage Kidney Disease
About this trial
This is an interventional treatment trial for End Stage Kidney Disease focused on measuring hemodialysis, ultrafiltration
Eligibility Criteria
Inclusion Criteria: Written consent of the participant after being informed At least 18 years of age End stage kidney disease patient undergoing hemodialysis Dry weight stable for a minimum of one month Interdialytic weight gain of >2 liters in the short interdialytic interval Exclusion Criteria: No informed consent was obtained Patients with a pacemaker or implanted medical device that prevents compliance with study regulations Patients treated with hemodiafiltration Patients treated with medium cut-off membranes (Theranova, Baxter) Patients with recurrent severe hyperkalemia after the short interdialytic interval (K+ concentration > 6.0 mmol/L, requiring more than 2 hours of dialysis to ameliorate the post-dialytic shift from other compartments. Women of childbearing age not using contraception
Sites / Locations
- Medical University of GrazRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Sequential HD - Conventional HD
Conventional HD - Sequential HD
In sequence A patients will be treated with sequential HD first, for a total of 8 session and then switched to a conventional HD schedule for another 8 sessions.
In sequence A patients will be treated with conventional HD first, for a total of 8 session and then switched to a sequential HD schedule for another 8 sessions.